Hyperion DeFi, Inc. (HYPD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $39.84M
Last updated: Nov 17, 2026 at 11:05 AM ET
Hyperion DeFi, Inc. (HYPD) Competitors
The companies most similar to Hyperion DeFi are EyePoint (EYPT), Heron Therapeuti (HRTX) and iBio, Inc. Common Stock (IBIO). By market cap, Hyperion DeFi ranks 6th of the 13 companies on this page; OKYO Pharma (OKYO) is the largest at $70.85M.
Peer Comparison
HYPD's ROIC of 22.2% is above the peer median of -51.9%, and its revenue growth of 1560.0% is above the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Hyperion DeFi (HYPD) | $39.84M | N/A | 20.3x | 474.9% | 22.2% | 1560.0% | 0.00% |
| EyePoint, Inc (EYPT) | $34.82M | N/A | 10.6x | 0.0% | N/A | -21.7% | 0.00% |
| Heron Therapeuti (HRTX) | $59.08M | N/A | 0.4x | -14.5% | -8.4% | -7.8% | 0.00% |
| iBio, Inc. Common Stock (IBIO) | $51.55M | N/A | 735.4x | 0.0% | N/A | 975.0% | 0.00% |
| Polyrizon Ltd. Ordinary Shares (PLRZ) | $26.84M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Pelthos Therapeutics Inc. (PTHS) | $29.24M | N/A | 0.5x | -199.5% | -95.4% | 0.0% | 0.00% |
| eXoZymes, Inc. (EXOZ) | $35.64M | N/A | N/A | 0.0% | -455.6% | 0.0% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Veru Inc (VERU) | $35.64M | N/A | N/A | 0.0% | N/A | 18.3% | 0.00% |
| OKYO Pharma Limited (OKYO) | $70.85M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Mink Therapeutics Inc (INKT) | $47.95M | N/A | 236.3x | 0.0% | N/A | 0.0% | 0.00% |
| Connect Biopharma Holdings Ltd (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| Peer median | $35.89M | N/A | 12.1x | 0.0% | -51.9% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Hyperion DeFi, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| EyePoint, Inc (EYPT) | EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States... | EYPT competitors |
| Heron Therapeuti (HRTX) | Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. | HRTX competitors |
| iBio, Inc. Common Stock (IBIO) | iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. | IBIO competitors |
| Polyrizon Ltd. Ordinary Shares (PLRZ) | Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. | |
| Pelthos Therapeutics Inc. (PTHS) | Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. | PTHS competitors |
| eXoZymes, Inc. (EXOZ) | eXoZymes, Inc. is a synthetic biochemical company in the United States. The company is headquartered in Monrovia, California. | EXOZ competitors |
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| Veru Inc (VERU) | Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. | VERU competitors |
| OKYO Pharma Limited (OKYO) | OKYO Pharma Limited, a preclinical biopharmaceutical company, is engaged in developing therapies for patients suffering from inflammatory eye diseases and eye... | |
| Mink Therapeutics Inc (INKT) | MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic... | INKT competitors |
| Connect Biopharma Holdings Ltd (CNTB) | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators... | CNTB competitors |
Frequently Asked Questions About HYPD
Who are Hyperion DeFi's main competitors?
The companies most similar to Hyperion DeFi include EyePoint (EYPT), Heron Therapeuti (HRTX), iBio, Inc. Common Stock (IBIO), Polyrizon Ltd. Ordinary Shares (PLRZ) and Pelthos Therapeutics (PTHS), listed from the closest match.
Who is Hyperion DeFi's biggest competitor?
OKYO Pharma (OKYO) is the largest of the similar companies at $70.85M; EyePoint (EYPT) is the closest match by business profile, size, sector and industry.
How does HYPD stock compare with its competitors?
HYPD's P/S is 20.3x against a peer median of 12.1x; its net margin is 474.9% against a peer median of 0.0%.
Which of Hyperion DeFi's competitors pays a higher dividend?
Hyperion DeFi pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Hyperion DeFi bigger than its competitors?
No. Hyperion DeFi is 6th by market cap among the 13 companies on this page; the largest is OKYO Pharma (OKYO) at $70.85M.
HYPD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors